XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Comprehensive Income - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Statement of Comprehensive Income [Abstract]        
Net income $ 491,597 $ 806,755 $ 619,680 $ 965,734
Changes in other comprehensive income/(loss):        
Unrealized gains on available for sale debt securities 9,325 6,025 10,950 11,150
Reclassification of unrealized gains on available for sale debt securities (7,988) (13,299) (16,942) (28,790)
Other comprehensive income/(loss) 1,337 (7,274) (5,992) (17,640)
Comprehensive income 492,934 799,481 613,688 948,094
Comprehensive income attributable to non-controlling interests 187,638 362,748 260,948 447,727
Comprehensive income attributable to Royalty Pharma plc $ 305,296 $ 436,733 $ 352,740 $ 500,367